GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of reimbursement — 17 things I got wrong before I got it right — 29 comments in the full submission. View in context.
500
c/glp1eu·submitted 1 months ago by u/osman_brandt

reimbursement — 17 things I got wrong before I got it right

Discussionbranch of 7 comments

The title is the argument: reimbursement — 17 things I got wrong before I got it right. Here is the rest of it. Nothing here is medical or legal advice, and eligibility questions have national answers that a pharmacist where you live can give you in minutes. Supply notices are issued nationally. A notice in one…

Read the full submission and all 29 comments →

This branch

7 comments, started 1 months ago
u/nikhil_asante22 points·1 months ago

Read the published reimbursement criteria where I live rather than asking. Took twenty minutes and answered everything.

replysharereportpermalink
u/bruno_dumitru5 points·1 months ago·edited

reimbursement is national, not European, and that is the whole board

replysharereportpermalink
u/sten_palacios-36 points·1 months ago

pack sizes differ, so per-month comparisons need care

replysharereportpermalink
u/vikram_asante18 points·1 months ago

Cross-border prescription recognition exists under EU rules but is conditional and narrower than commonly assumed, with requirements about the prescription’s form and content.

replysharereportpermalink
u/fabio_ibarra15 points·1 months ago

Disagree. That is one member state’s reimbursement rule and it does not generalise across the union.

replysharereportpermalink
u/osman_brandtOP7 points·1 months ago

Assumed a prescription would be honoured across the border. It was not, and the rules are clear once you actually read them.

replysharereportpermalink
u/ilias_steiner5 points·1 months ago

the reimbursement criteria are published in most member states

replysharereportpermalink

← back to the whole thread

About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.